SCHEMBL28009374

SCHEMBL28009374

COCCc1ccc(C=O)cn1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.41
FDPS P14324 1/20 0.41
ALDH1A1 P00352 7/20 0.38
CYP2A6 P11509 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
SMN1; SMN2 Q16637 3/20 0.37
MAPT P10636 3/20 0.37
LMNA P02545 2/20 0.37
HPGD P15428 1/20 0.37
PTGER4 P35408 1/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
TSHR P16473 1/20 0.35
CCNB2 O95067 1/20 0.35
CDK1 P06493 1/20 0.35
CCNB1 P14635 1/20 0.35
CDK5 Q00535 1/20 0.35
CDK5R1 Q15078 1/20 0.35
CCNB3 Q8WWL7 1/20 0.35
KCNJ1 P48048 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7993750 0.83 KDM4E (0.40) KDM4EFDPSALDH1A1CYP2A6L3MBTL1
SCHEMBL7982148 0.81 ALDH1A1 (0.44) KDM4EFDPSALDH1A1CYP2A6L3MBTL1
SCHEMBL2172039 0.79 KDM4E (0.41) KDM4EFDPSALDH1A1CYP2A6L3MBTL1
SCHEMBL4237400 0.76 GABRP (0.40) KDM4EALDH1A1CYP2A6L3MBTL1SMN1; SMN2
SCHEMBL2562397 0.76 FDPS (0.37) KDM4EFDPSALDH1A1CYP2A6L3MBTL1
SCHEMBL6935097 0.76 CCR1 (0.41) KDM4ESMN1; SMN2
SCHEMBL1943866 0.75 KDM4E (0.53) KDM4EFDPSALDH1A1CYP2A6L3MBTL1
SCHEMBL29417023 0.75 KDM4E (0.53) KDM4EFDPSALDH1A1CYP2A6L3MBTL1
SCHEMBL29952238 0.75 KDM4E (0.43) KDM4EFDPSALDH1A1CYP2A6L3MBTL1
SCHEMBL7999255 0.75 KDM4E (0.43) KDM4EFDPSALDH1A1CYP2A6L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104582709-A N-alkyl 2-(disubstituted)alkynyladenosine-5-uronamides as A2A agonists LEWIS AND CLARK PHARMACEUTICALS INC 2015-04-29 CN disclosed